None listed
Conditions
Interventions
Intervention1: Questionnaire: The questionnaire has questions pertaining to diagnosis of BPD
First, second, and third prescription choices for various phases and types of BPD
use of antidepressants for bipolar depression (class, mono-therapy/ combination therapy, efficacy, effect on disease spectrum)
prophylactic therapy of BPD
use of Psychoeducation/ Interpersonal and Social Rhythm Therapy/ Electroconvulsive therapy in BPD
and reference to treatment guidelines.
Control Intervention1: Nil: Nil
Sponsors
Glaxosmithkline Pharmaceuticals Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Psychiatrists (with postgraduate degree/diploma/fellowship in psychiatry) practicing for at least 3 years after post graduation in India. 2. Psychiatrists willing to sign the consent form 3. Psychiatrists willing to complete the survey
Exclusion criteria
Exclusion criteria: 1. Psychiatrists practicing for fewer than 3 years after post graduation in India. 2. Psychiatrists not willing to sign the consent form 3. Psychiatrists not willing to complete the survey questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The usage pattern of pharmacological and non-pharmacological interventions by Psychiatrists practicing in India for bipolar disordersTimepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Determination of gaps (if any) in CANMAT guidelines and treatment chosen in the clinical practice in India 2. Determination of the extent of use of antidepressants in bipolar disorder by psychiatrists practising in India 3. Determination of the role of Psychoeducation, Interpersonal and Social Rhythm Therapy or ECT in BPD by psychiatrists practising in India Timepoint: 2 months | — |
Countries
India
Contacts
Public ContactSamuda Kanakapura
Glaxosmithkline Pharmaceuticals
Outcome results
None listed